These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Progress of immunotherapy in the treatment of malignant melanoma. Ariyan S Yale J Biol Med; 1975 Nov; 48(5):423-9. PubMed ID: 1108459 [No Abstract] [Full Text] [Related]
3. Immune response and non-specific immunotherapy in melanoma. El-Domeiri AA Ann R Coll Surg Engl; 1978 Mar; 60(2):117-20. PubMed ID: 637492 [TBL] [Abstract][Full Text] [Related]
4. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)]. Knopf B; Wätzig V; Knöll B Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194 [TBL] [Abstract][Full Text] [Related]
5. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report. Nathanson L; Clark DA Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321 [No Abstract] [Full Text] [Related]
6. [Possibilities of immunotherapy in malignant melanoma]. Lewis MG Hautarzt; 1978 Dec; 29(12):619-24. PubMed ID: 363650 [TBL] [Abstract][Full Text] [Related]
15. [BCG-treatment of malignant melanoma]. Borberg H Internist (Berl); 1975 Oct; 16(10):482-5. PubMed ID: 1107254 [No Abstract] [Full Text] [Related]
16. Results of adjuvant BCG immunotherapy in malignant melanoma. Wätzig V; Knopf B Arch Geschwulstforsch; 1981; 51(6):493-6. PubMed ID: 7332442 [TBL] [Abstract][Full Text] [Related]
17. [Use of immunotherapy in the treatment of malignant melanoma of the skin]. Kristensen E Ugeskr Laeger; 1976 Feb; 138(8):468-73. PubMed ID: 1258215 [No Abstract] [Full Text] [Related]
18. Low doses of chemotherapy to inhibit suppressor T cells. Berd D Prog Clin Biol Res; 1989; 288():449-58. PubMed ID: 2566177 [No Abstract] [Full Text] [Related]
19. [Results in the use of immunochemotherapy in patients with cutaneous malignant melanoma]. Calbo L; Gorgone S; Palmeri R; Salibra M; Melita P Chir Ital; 1983 Aug; 35(4):519-25. PubMed ID: 6680859 [TBL] [Abstract][Full Text] [Related]
20. Local active immunotherapy for malignant melanoma. Serrou B; Dubois JB; Meiss L; Romieu C Panminerva Med; 1975; 17(5-6):182-6. PubMed ID: 1161316 [No Abstract] [Full Text] [Related] [Next] [New Search]